What is MicroPort CardioFlow Medtech Pre-Tax Income?
Pretax income is the income that a company earns before paying income taxes. MicroPort CardioFlow Medtech's pretax income for the
six
months ended in Dec. 2023 was HK$-315.0 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-507.1 Mil.
MicroPort CardioFlow Medtech's pretax margin was -180.23%.
During the past 6 years, MicroPort CardioFlow Medtech's highest Pretax Margin was -90.96%. The lowest was -672.14%. And the median was -179.78%.
MicroPort CardioFlow Medtech Pre-Tax Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of MicroPort CardioFlow Medtech's Pre-Tax Income
For the Medical Devices subindustry, MicroPort CardioFlow Medtech's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroPort CardioFlow Medtech's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where MicroPort CardioFlow Medtech's Pre-Tax Income falls into.
MicroPort CardioFlow Medtech Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-507.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MicroPort CardioFlow Medtech (HKSE:02160) Pre-Tax Income Explanation
MicroPort CardioFlow Medtech's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 6 years, MicroPort CardioFlow Medtech's highest Pretax Margin was -90.96%. The lowest was -672.14%. And the median was -179.78%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MicroPort CardioFlow Medtech Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
MicroPort CardioFlow Medtech (HKSE:02160) Business Description
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02160 has been successfully added to your 